Following publication of the Strategy, a detailed implementation plan was published in 2014. Most of those actions were implemented in May 2016, the O’Neill Review was published in response.
The governments response to the O’Neill review included the commitment to a new set of ambitions that built on existing programmes - as shown on this slide.
The UK programme is focused on delivery of those ambitions through 4 core programmes (infection, prescribing, diagnostics, animal use) and 3 supporting work-streams (surveillance and behaviour, education and training, global and domestic research and drug pipeline activity).
As I mentioned earlier, we have been reviewing the strategy and you will hear more on this later The governance arrangement for delivery will be explained in the next sessions
Age and sex adjusted between 500 and 600 prescriptions per year
Nearly back to 2011 levels
National Campaign ran from 23 Oct to 18 Dec
23rd October: 8 week campaign launched Antibiotic resistance is a complex problem that requires a high profile campaign to land an impactful message around personal risk which motivates the audience to change their behaviour without deterring those who do need antibiotics. Our audience do not need to understand in scientific detail how resistance works they simply need to know that they don’t work for everything leading them to trust their doctors advice.
Core campaign proposition: Taking antibiotics when you don’t need them means they are less likely to work for you in the future. Key channels: The campaign needed to reach a large audience and motivate action - TV, PR and partnerships are viewed as key channels to achieve this. Call to action: Take your doctors’ advice.
Channels – TV, radio, OOH, press ads, social media, PR - media medics event, media day in Colindale, partnerships
TV ad - worked really well in the pilot to deliver a very complicated message. Therefore for the national we made minimal changes which included: giving greater prominence to the CTA by streamlining information provided on the end frame and including a voice over so the audience can hear the CTA as well as see it Removed references to colds, flu and viruses in the song as this proved potential for confusion for the audience
PARTNERSHIPS Empowering GPs, prescribing nurses and dentists with: TYI prescription pad Briefings, direct and via member organisations and stakeholders: Professional leaders within PHE with Royal Colleges; the AMR board Antibiotic Guardians to work alongside KAW as the professional ask for HCPS
Materials to influence audiences in waiting rooms which included posters, leaflets and screens
Wicked problems are highly impervious to resolution, difficult to define, arise form inter-dependent and mulicausal factors and socially complex
Susan hopkins ag 2018
Progress on the Government’s ambitions to tackle
AMR and Reducing inappropriate prescribing by 50%
Deputy Director, National Infection Service, Public Health England
HCAI & AMR Division
NICE Annual Conference 2018
Chair of English Surveillance Programme on Antibiotic Utilisation and
Resistance Oversight Group
Member of MHRA anti-infectives group
Member of NICE common infections guideline group
Member of ECDC working groups
Partially funded by NIHR HPRU for HCAI & AMR (Oxford and Imperial)
No pharma sponsorship
National toolkits & training for professionals
Hospital Antibiotic review and assessment for antibiotics started for sepsis
Hospital Reduction in total antibiotic consumption per 1,000 admissions
Reduction in broad (carbapenem & pip/tazobactam) antibiotic consumption
per 1,000 admissions
Hospital Increase in Access group from EML
Community Reduce antibiotic prescribing levels (0.965 items/STARPU)
Community Reduction in Trimothoprim : Nitrofurantoin
Community Reduce/ remain broad spectrum antibiotics <10%
Dr Diane Ashiru-Oredope
Long term trends inAntibiotic Use
AMR Local Indicator